Press "Enter" to skip to content

New patent for Teva Pharm drug AIRDUO DIGIHALER

0
Copyright © DrugPatentWatch. Originally published at New patent for Teva Pharm drug AIRDUO DIGIHALER

Annual Drug Patent Expirations for AIRDUO+DIGIHALER
Annual Drug Patent Expirations for AIRDUO+DIGIHALER

Airduo Digihaler is a drug marketed by Teva Pharm and is included in one NDA. It is available from four suppliers. There are twenty-three patents protecting this drug.

Drug patent litigation for AIRDUO DIGIHALER.

The generic ingredient in AIRDUO DIGIHALER is fluticasone propionate; salmeterol xinafoate. Four suppliers are listed for this compound. Additional details are available on the fluticasone propionate; salmeterol xinafoate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent for Teva Pharm drug AIRDUO DIGIHALER
Find your next blockbuster

Get accurate and timely intelligence — in just a few clicks

✓ Free trial

✓ No credit card

 

DrugPatentWatch - Make Better Decisions